Profil
Deepali Suri worked as an Executive Director of Clinical Operations at Pharmacyclics LLC from 2012 to 2017.
Prior to that, she was a Vice President of Clinical Operations at Sunesis Pharmaceuticals, Inc. She received her undergraduate and graduate degrees from the University of Delhi.
Ehemalige bekannte Positionen von Deepali Suri
| Unternehmen | Position | Ende |
|---|---|---|
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 01.12.2017 |
| VIRACTA THERAPEUTICS, INC. | Geschäftsführer | - |
Ausbildung von Deepali Suri
| University of Delhi | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
